Next Article in Journal
Genome-Wide Identification and Analysis of the NAC Transcription Factor Gene Family in Garden Asparagus (Asparagus officinalis)
Previous Article in Journal
Genome-Wide RNA Sequencing Analysis in Human Dermal Fibroblasts Exposed to Low-Dose Ultraviolet A Radiation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 13
Issue 6
10.3390/genes13060975
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder

by
Mohammad H. Rahbar
1,2,3,*,
Maureen Samms-Vaughan
4,
Sori Kim
2,5,
Sepideh Saroukhani
2,3,
Jan Bressler
1,6,
Manouchehr Hessabi
2,
Megan L. Grove
1,6,
Sydonnie Shakspeare-Pellington
4 and
Katherine A. Loveland
7
1
Department of Epidemiology, Human Genetics, and Environmental Sciences (EHGES), School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
2
Biostatistics/Epidemiology/Research Design (BERD) Component, Center for Clinical and Translational Sciences (CCTS), The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
3
Division of Clinical and Translational Sciences, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
4
Department of Child & Adolescent Health, The University of the West Indies (UWI), Mona Campus, Kingston 7, Jamaica
5
Department of Biostatistics & Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
6
Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
7
Louis A Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA
*
Author to whom correspondence should be addressed.
Genes 2022, 13(6), 975; https://doi.org/10.3390/genes13060975
Submission received: 15 March 2022 / Revised: 9 May 2022 / Accepted: 27 May 2022 / Published: 29 May 2022
(This article belongs to the Section Technologies and Resources for Genetics)
Versions Notes

Abstract

:
Glutathione S-transferases (GST) are involved in the detoxification of exogenous chemicals including lead (Pb). Using data from 344 pairs of autism spectrum disorder (ASD) cases and age- and sex-matched typically developing (TD) controls (2–8 years old) from Jamaica, we investigated the interaction between three GST genes and ASD status as determinants of blood Pb concentrations (BPbCs). We found that ASD cases had lower geometric mean BPbCs than TD children (1.74 vs. 2.27 µg/dL, p < 0.01). Using a co-dominant genetic model, ASD cases with the Ile/Val genotype for the GSTP1 Ile105Val polymorphism had lower GM BPbCs than TD controls, after adjusting for a known interaction between GSTP1 and GSTT1, child’s parish, socioeconomic status, consumption of lettuce, fried plantains, and canned fish (Ile/Val: 1.78 vs. 2.13 µg/dL, p = 0.03). Similarly, among carriers of the I/I or I/D (I*) genotype for GSTT1 and GSTM1, ASD cases had lower adjusted GM BPbCs than TD controls (GSTT1 I*: 1.61 vs. 1.91 µg/dL, p = 0.01; GSTM1 I*: 1.71 vs. 2.04 µg/dL, p = 0.01). Our findings suggest that genetic polymorphisms in GST genes may influence detoxification of Pb by the enzymes they encode in Jamaican children with and without ASD.

1. Introduction

Lead (Pb) is a toxic metal that has deleterious effects on the human body and has been recognized as a major public health risk, particularly in developing countries [1,2,3]. Pb poisoning has been reported as a factor associated with neurodevelopmental impairment during childhood [4]. Blood Pb concentrations (BPbCs) ≥ 5 μg/dL were defined as “level of concern” by the US Centers for Disease Control and Prevention (CDC) [5], with no Pb level currently considered safe [6,7,8].
Some but not all studies have previously found associations between environmental exposure to Pb and autism spectrum disorder (ASD). For example, an age-matched case–control study of 40 pairs of boys 4–8 years old from Kuwait reported that ASD cases had a significantly higher level of Pb in the hair than TD controls ((median Pb levels in ASD cases: 6.75 μg/g) vs. (median Pb levels in TD controls: 3.20 μg/g), p < 0.01) [9]. A recent study of 52 ASD cases and 30 TD controls (3–12 years old) from the Middle East found that mean red blood cell Pb concentrations were significantly lower for the TD children than for the children with ASD (4.73 μg/dL vs. 6.79 μg/dL, p < 0.01) [10]. Another age- and sex-matched study, from India, also showed that children with ASD and different levels of functioning had significantly higher Pb levels in hair samples (p < 0.01) than TD controls [11]. Furthermore, a positive association was observed between hair levels of Pb and both verbal communications and general impression severity scores in children with ASD from Saudi Arabia (p = 0.02 and p < 0.01, respectively) [12]. In contrast, the investigators in another study that reported significantly lower urine Pb concentrations in children with ASD than in TD controls (1.19 μg/g creatinine vs. 4.63 μg/g creatinine, p < 0.01) suggested that this could be due to a decreased ability to detoxify heavy metals [13]. On the other hand, a study of 2–5-year-old children in California enrolled in Childhood Autism Risk from Genetics and Environment (CHARGE) that compared mean BPbCs between 37 ASD cases and 15 TD controls did not show any significant differences (p = 0.97) [14]. Notably, most of the aforementioned studies did not adjust their findings to control for potential confounding variables such as food consumed and other environmental exposures. However, our results from the Epidemiological Research on Autism in Jamaica (ERAJ) study in Jamaica showed an inverse association of Pb with ASD from univariable general linear models (GLM) and quantile regression models as well as a weighted quantile sum regression (WQS) mixture index score with ASD, though when adjusted for potential confounding variables including diet, this association was no longer statistically significant. This finding could be due to some children with ASD eating a more restricted diet compared to TD children, possibly due to the higher rate of gastrointestinal symptoms and sensory sensitivities [15].
In addition to the need for adjusting for the potential confounding role of dietary intake and other potential confounding variables while assessing associations between BPbCs and ASD, several studies have also suggested that differences in Pb concentrations could be due to varied detoxification and excretory mechanisms in children with and without ASD [10,16,17]. It has also been shown that Pb-induced toxicity is associated with chronic oxidative stress and mitochondrial dysfunction [18,19,20,21].
Glutathione S-transferases (GST) are a family of enzymes that play a key role in the detoxification of xenobiotics, including heavy metals such as Pb, by catalyzing their conjugation with reduced glutathione (GSH), and also by protecting cells against oxidative stress [22,23,24,25]. GST genes (e.g., GSTP1, GSTT1, and GSTM1) are highly polymorphic metabolic genes that encode GST enzymes [23]. Polymorphisms in these genes may influence their biological function and detoxification capacity. For example, null alleles of GSTT1 and GSTM1 can completely interrupt the enzymes’ function [26]. There are also findings suggesting that certain GST polymorphisms may influence the individuals’ susceptibility to the cytotoxic effects of Pb [27,28,29]. In addition, dysfunctions in the glutathione and mitochondrial systems, as well as the presence of chronic oxidative stress in the brains and blood of children with ASD, have been reported previously [30,31,32,33,34,35,36]. There is also evidence of associations between GST gene polymorphisms and ASD. For example, findings of a family-based association study showed significant over-transmission of a haplotype with two polymorphisms in GSTP1 (Ala114Val and Ile105Val) in the mothers of children with ASD [37]. Other case–control studies reported a significant association between the GSTM1 null polymorphism and about two times higher odds of ASD [36,38]. We have also previously reported a significant interaction between GSTT1 and GSTP1 in relation to ASD indicating that Jamaican children with ASD who are heterozygous for the GSTP1 Ile105Val polymorphism have nearly three times higher odds of also carrying the GSTT1 D/D genotype than TD controls when using a co-dominant genetic model for GSTP1 [39]. These studies seem to indicate that genetic variation may convey varied Pb-induced susceptibility to neurodevelopmental disorders such as ASD. However, research on this topic has been very limited so far.
We have carried out a long-term collaborative study to assess the role of additive and interactive associations of environmental exposures to six metals and three GST genes (GSTP1, GSTM1, and GSTT1) in the development of ASD in Jamaican children. Although our previous study did not find any significant interactions between BPbCs and genotypes for any of the aforementioned three GST genes in relation to ASD status, using different conditional logistic regression (CLR) models, (all p for interaction between BPbCs and each of the GST genes > 0.49), a marginally significant interactive association of GSTP1 with a mixture of Pb, Hg, and Mn was detected (p = 0.07) based on a negative association generalized weighted quantile sum (gWQS) model [40]. From another ERAJ study, we also reported significant interactions between GSTP1 and ASD status in relation to blood arsenic (p = 0.04) [41] and blood mercury (p < 0.01) [42], as well as blood aluminum concentrations (p < 0.02) [43]. Based on the accumulation of evidence for the complex role of metabolic genes in detoxification of heavy metals in relation to ASD, we investigated the possible interaction of each of the three GST genes with ASD status and possible pairwise gene–gene interactions in relation to BPbCs of Jamaican children.

2. Materials and Methods

2.1. Epidemiological Research on Autism in Jamaica (ERAJ) Studies

ERAJ and ERAJ-Phase 2 (ERAJ-2) are 1:1 age- and sex-matched case–control studies of Jamaican children 2–8 years old with ASD and their TD controls that investigated potential individual or interactive associations between environmental exposures and three GST genes (GSTP1, GSTT1, and GSTM1) in relation to ASD as previously described [44]. The Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) [45] and Autism Diagnostic Interview-Revised (ADI-R) [46] were administered to determine ASD status for children included in the Jamaican Autism Database. The absence of developmental disorders in the TD control children was determined based on a score < 6 for the Social Communication Questionnaire (SCQ) [47].
We also elicited responses to a socioeconomic status (SES) questionnaire and to a food frequency questionnaire [48], and collected 4–5 mL of whole blood from each child for assessing exposure to lead and some other metals and for use in the genotyping assays.
Here, we used data from 344 ASD cases, and age- (±6 months) and sex-matched TD controls (n = 688 that includes 344 matched pairs), enrolled in the ERAJ studies based on the study protocol that was approved by the Institutional Review Boards (IRBs) of UTHealth, UWI, and Michigan Department of Health and Human Services (MDHHS), in Lansing, Michigan. Written informed consent was obtained from parents and assent from the children when applicable (for details, please refer to the section on “Institutional Review Board Statement”).

2.2. Assessment of Pb Exposure

A 2 mL aliquot of the 4–5 mL sample of whole venous blood collected after assessment of children for ASD or TD control status was used to measure BPbCs. Details regarding the processing and storage of samples at the Caribbean Genetics (CARIGEN) lab at UWI, their shipment to MDHHS, and their analysis and quality control (QC) at MDHHS have been reported previously [49]. Two different limits of detection (LoD) were established by MDHHS for Pb during the two successive phases of the ERAJ study due to changes in technology (0.25 ug/dL in ERAJ and 0.30 ug/dL in ERAJ-2). However, in both phases of the ERAJ studies, all of the BPbCs were above their respective LoDs.

2.3. Genetic Analysis

In this study, we analyzed variants in three different GST genes and their possible associations with ASD, as well as interactive associations between genotypes for the three genes and ASD status in relation to BPbCs. These variants included the GSTP1 Ile105Val polymorphism (rs1695) and insertion/deletion polymorphisms in both GSTT1 and GSTM1. Methods for DNA extraction and genotyping have been described previously [15,39,42]. There are three genotypes for the GSTP1 polymorphism (Ile/Ile, Ile/Val, Val/Val) and two for GSTT1 and GSTM1 (D/D and I*) since I/I and I/D cannot be distinguished. Three genetic models for GSTP1 (dominant, co-dominant, and recessive) and one genetic model for GSTT1 and GSTM1 (recessive) were tested.

2.4. Statistical Analysis

We reported the geometric mean (GM) after using the natural logarithm (ln) to transform the BPbCs due to their skewed distribution. Using conditional logistic regression (CLR) models, we compared ASD cases and TD control groups with respect to various characteristics of children and their parents, including the distributions of the children’s GSTP1, GSTM1, and GSTTI genotypes and their dietary or environmental exposures. Using univariable general linear models (GLMs) in which the log-transformed BPbCs were the dependent variable, we also assessed the possible association of each of the three GST genes with ASD status, sociodemographic characteristics, and consumption of various types of food. In order to account for the potential clustering effect of 344 matched pairs in all GLMs, we entered 343 dummy variables as described previously [42].
We also used multivariable GLMs to explore the possible interactive associations between the genotypes for each of the three GST genes and ASD status in relation to BPbCs. In addition, in adjusted multivariable GLMs, we included the parish in which the child was born, car ownership by the family as an index of SES, and consumption of lettuce, fried plantains, and sardine or mackerel fish, which have previously been identified as having significant associations with ASD status and BPbCs [15,50]. In order to minimize potential effects of multicollinearity, we only retained one of any two correlated variables after initially checking pairwise correlations between all pairs of individual covariates and finding that the model became unstable when both were added. We assessed two-way interactions between genotypes of the three GST genes in relation to BPbCs using multivariable GLMs, and also accounted for a previously reported interaction between GSTP1 and GSTT1 when the adjusted models included these two genes. We used the CONTRAST statement in PROC GLM in SAS [51] to assess whether the differences between GM BPbCs found when comparing ASD cases and TD controls were significantly different between/among those with different genotypes for the three GST genes. Similarly, we tested whether there was a significant difference in the GM BPbCs between/among ASD cases and TD controls by GST genotype. Unadjusted and adjusted GM BPbCs were calculated for both ASD cases and TD controls with different GST genotypes. A statistical threshold of p < 0.05 was used to determine statistical significance for all statistical tests without accounting for multiple comparisons. We utilized SAS 9.4 software for all analyses [52].

3. Results

At enrollment, 71.8% of ASD cases and 74.7% of the TD controls were 48 months or older. Almost all of the participants in this study were Afro-Caribbean (94.5% of ASD cases, 97.1% of TD control children, as well as over 95% of their parents). Higher proportions of both parents of ASD cases were older than those of the TD controls (19.5% of the mothers and 43.8% of fathers of ASD cases were 35 years or older vs. 11.8% of mothers and 30.3% of fathers of TD controls, all p < 0.01) when their children were born. Similarly, 62.3% of ASD cases and 48.3% of TD controls had at least one parent who had attained postsecondary education (p < 0.01). A larger proportion of ASD cases were from families with higher SES compared to TD controls, with 54.1% of ASD case families owning a car versus 41.9% of car ownership among TD control families (p < 0.01). There was no significant difference in the frequencies of GSTP1, GSTM1, and GSTT1 genotypes between ASD cases and TD controls (all p > 0.07). Among TD children, 24.0% and 25.9% had the null genotype (DD) for GSTM1 and GSTT1, respectively. The arithmetic mean BPbC was 2.41µg/dL for ASD cases and 2.94 µg/dL for TD controls (p < 0.01). Details regarding characteristics of children and their parents are provided in Table 1.
Comparison of the consumption of various food items between ASD case and TD control children revealed that compared to TD control children, ASD cases consumed lower levels of root vegetables (yam, sweet potato, or dasheen (matched odds ratio (MOR) (95% CI) = 0.59 (0.43, 0.82), p < 0.01) and carrot or pumpkin (MOR = 0.44, (0.30, 0.67), p < 0.01). Similar comparisons of the distributions of other dietary and environmental factors are displayed in Table 2.
In Table 3, we reported on potential associations of ASD status and various sociodemographic and dietary exposures, as well as children’s genotype for GST genes with BPbCs based on univariable GLMs. We found a significant association between ASD status and BPbCs (GM BPbC for ASD group = 1.74 µg/dL vs. 2.27 µg/dL for the TD control group, p < 0.01). We also found that child’s age at enrollment, place of child’s birth (parish), and SES were significantly associated with BPbCs (all p ≤ 0.02). Regarding dietary factors, we found that consumption of root vegetables, namely yam, sweet potato or dasheen, and carrot or pumpkin, as well as some types of fruits including tomatoes, ackee, avocado, and fried plantains were significantly associated with BPbCs (all p < 0.03). Similarly, we found a significantly higher GM BPbC among children who had higher seafood consumption (more than 6 meals per week), consumption of fresh water fish (pond fish and tilapia), canned fish (sardine and mackerel), and salted fish and shellfish (all p < 0.02). The associations between other independent variables and BPbCs were marginally significant (callaloo, broccoli, or pak choi (p = 0.07); green banana (p = 0.05); saltwater fish (p = 0.05)). There were no significant associations between any of the GST genes and BPbCs (GSTT1 I* (I/I or I/D): p = 0.52; GSTM1 I* (I/I or I/D): p = 0.40; GSTP1: p > 0.77 for all pairwise comparisons).
In multivariable GLMs, we did not find any significant interactions between GST genes and ASD status in relation to BPbCs, either in the unadjusted model, or after accounting for the interaction between GSTT1 and GSTP1 and further adjustment for place of child’s birth (parish), SES (car ownership by the family), consumption of lettuce, fried plantains, and sardine or mackerel fish (all overall interaction p > 0.5). For example, using a co-dominant genetic model for GSTP1 and after adjusting for the aforementioned variables, although not statistically significant, we found that while ASD cases with Ile/Ile genotype had lower GM BPbC than those with Ile/Val genotype (1.55 µg/dL vs. 1.78 µg/dL, p = 0.25), ASD cases with either Ile/Ile or Ile/Val genotype had a higher GM BPbC than those with Val/Val genotype (GM BPbC among ASD cases with Ile/Ile vs. Val/Val genotype for GSTP1: 1.55 µg/dL vs. 1.50 µg/dL, p = 0.82; GM BPbC among ASD cases with Ile/Val vs. Val/Val genotype for GSTP1: 1.78 µg/dL vs. 1.50 µg/dL, p = 0.19). Similar non-significant differences were observed among TD children with various genotypes for GSTP1 using the co-dominant genetic model (all p ≥ 0.16). Similarly, using the recessive model for GSTT1, although the differences were not statistically significant, we found that TD children with I/I or I/D genotype had lower BPbCs than those with DD genotype (1.91 µg/dL vs. 1.99 µg/dL, p = 0.71), whereas ASD cases with I/I or I/D genotype had higher GM BPbC than those with DD genotype (1.61 µg/dL vs. 1.60 µg/dL, p = 0.97). Additional details about the comparisons of GM BPbC among ASD cases and TD control children with various genotypes for GST genes are provided in Table 4.
Although the interaction between genotype for GST genes and ASD status was not significant in relation to BPbCs, ASD cases with certain genotypes for GST genes had significantly lower GM BPbC than TD control children with the same genotype for GST genes. Specifically, using the co-dominant model for GSTP1, while there was no significant association between ASD status and BPbCs among children with Ile/Ile genotype in both unadjusted and adjusted models, ASD cases with Ile/Val genotype had significantly lower GM BPbC than TD control children with the same genotype for GSTP1, in both unadjusted and adjusted models (unadjusted GM: 1.78 µg/dL vs. 2.31 µg/dL, p < 0.01; adjusted: 1.78 µg/dL vs. 2.13 µg/dL, p = 0.03). Similarly, using the co-dominant model for GSTP1, ASD cases with Val/Val genotype also had significantly lower GM BPbC than TD control children with the same genotype for GSTP1 in the unadjusted model (1.68 µg/dL vs. 2.30 µg/dL, p = 0.02); however, the difference became marginally significant after adjusting for the aforementioned covariates (1.50 µg/dL vs. 1.94 µg/dL, p = 0.06).
In similar analyses for GSTT1, we did not find any significant interaction between GSTT1 and ASD status in relation to BPbCs before and after adjusting for the aforementioned covariates (p = 0.73 and p = 0.77, respectively). However, we found a significant difference in the unadjusted and adjusted GM BPbC between ASD cases and TD control children with I/I or I/D genotype for GSTT1 (unadjusted GM: 1.72 µg/dL vs. 2.26 µg/dL, p < 0.01; adjusted GM: 1.61 µg/dL vs. 1.91 µg/dL, p = 0.01). The difference between unadjusted and adjusted GM BPbC for ASD cases and TD control children with DD genotype was marginally significant (both p = 0.09). Details for the difference in GM BPbC between ASD cases and TD control children by GSTT1 genotypes are displayed in Table 5.
There were no significant interactive associations between GSTM1 and ASD status in relation to BPbCs before and after adjusting for parish at child’s birth, SES (car ownership by the family), and consumption of lettuce, fried plantains, and sardine or mackerel fish (unadjusted: p = 0.57, adjusted: p = 0.82). However, in the unadjusted model, we found that ASD cases with the GSTM1 D/D genotype had a significantly lower GM BPbC than TD controls with the same genotype (1.67 µg/dL vs. 2.31 µg/dL, p = 0.01), although this difference was not significant after adjusting for the aforementioned covariates (1.58 µg/dL vs. 1.81 µg/dL, p = 0.28). Among those with the GSTM1 I/I or I/D genotype, ASD cases had significantly lower GM BPbC than TD controls before and after adjusting for the same covariates (unadjusted GM: 1.78 µg/dL vs. 2.26 µg/dL, p < 0.01; adjusted GM: 1.71 µg/dL vs. 2.04 µg/dL, p = 0.01). Details for the difference in GM of BPbC between ASD cases and TD controls by GSTM1 genotypes are shown in Table 5.

4. Discussion

To our knowledge, this is the first study to investigate whether the associations between BPbCs and GST genes depend on ASD status in 2–8-year-old Jamaican children by assessing possible interactions of GSTP1, GSTT1 and GSTM1 and ASD status in relation to BPbCs. Although we did not find any statistically significant interactions between any of the three GST genes and ASD status in relation to BPbCs, overall, ASD children tended to have lower BPbCs than TD children, and the GM difference in BPbCs between ASD cases and TD controls was either significant or marginally significant only among children with certain genotypes for GST genes.
For example, using either a co-dominant or dominant genetic model for GSTP1, our findings suggest that in the presence of at least one GSTP1 Val105 allele, children with ASD had significantly lower GM BPbC than TD children, before and after adjusting for the GSTT1 and GSTP1 interaction, as well as SES, place of child’s birth (parish), and consumption of fried plantains, lettuce, and canned fish. Similarly, even though there were no significant interactions found between either the GSTT1 or GSTM1 genes and ASD status in relation to BPbCs, our findings from the adjusted model suggested that GM BPbCs were significantly lower in children with ASD than in TD children only among those with I* genotypes for either GSTT1 or GSTM1.
The inverse associations between BPbCs and ASD status that we found in our additive models are consistent with previous studies that assessed Pb concentrations in hair, urine and blood samples of children with and without ASD in different regions of the world. For example, findings from a case–control study of 354 ASD cases and 241 TD children (0–15 years old) in Japan reported a significantly lower Pb level in hair samples from ASD cases than from TD controls (mean (SD) = 2.52 (0.37) parts per billion (ppb) for children with ASD vs. 2.89 (0.34) ppb for TD controls, p < 0.01) only among male participants. [54]. Though marginally significant, an age- and sex-matched case–control study of 2–9 year-old children (74 ASD cases vs. 74 TD controls) in Russia also reported ASD cases had a lower mean hair Pb level than TD controls (mean (SD) (95% CI) for ASD = 0.45 μg/g (0.21, 0.61) vs. TD = 0.59 μg/g (0.30, 1.05), p = 0.06) [55]. Another study, from Turkey, that compared 30 ASD cases and 20 TD control children (3–12 years old) reported a significantly lower urine Pb concentration in children with ASD than in unmatched TD children (mean (95% CI) for ASD = 1.19 μg/g creatinine (-0.79, 3.17) vs. TD = 4.63 μg/g creatinine (0.80, 8.46), p < 0.01) [13]. Similarly, in a study from Malaysia, Wahil et al. compared 81 ASD cases and 74 TD control children (3–6 years old) and reported significantly lower GM urinary Pb levels in ASD cases compared to unmatched TD controls (ASD mean (SD) = 0.26 μg/dL (0.31), TD mean (SD) = 0.58 μg/dL (0.41), p < 0.01) [16]. In another case–control study in Pakistan (age- and sex-matched), Rahbar et al. compared 30 ASD cases and 30 TD controls (2–12 years old) and reported significantly lower GM BPbC in children with ASD compared to their age- and sex-matched TD controls (GM for ASD = 6.37 µg/dL vs. TD = GM 7.68 µg/dL, p = 0.05) [56]. However, as we mentioned earlier, there are also studies reporting contrasting findings, including higher Pb levels in children with ASD than in TD children as measured in various biological samples such as hair [9], nails [11], and red blood cells [10], as well as no association between BPbCs and ASD that was reported in the CHARGE study [14]. In addition to differences in the design and population and level of controlling for potential confounding variables such as food consumption that were mentioned earlier, a possible explanation for the inconsistent findings could be variation in biomarkers used for assessment of Pb exposure in these studies. Various specimens, including blood, urine, hair, teeth, nails, and bone, can be used to assess Pb exposure in humans. Studies have reported that while Pb levels in tooth dentin and enamel and bone are considered biomarkers of cumulative Pb exposure over a long term, BPbC represents more recent exposure [57]. BPbC is the most commonly used biomarker for Pb exposure [50,58]. Alternative biomarkers for monitoring exposure to Pb have been used by several studies in the literature; however, it is still unclear whether alternative biomarkers are superior to BPbCs as indicators of Pb exposure. Currently, BPbC measurements are considered as the most reliable recent Pb exposure indicator; however, repeated measurements may be needed for assessment of fluctuations in Pb exposure over time [59]. The lower BPbCs in ASD cases compared to TD controls that we found in our study, which were also reported in several previous studies, could possibly be explained by various behavioral and eating habits of children with and without ASD that may result in lower exposure to Pb in children with ASD than in TD children. For example, there is well-established evidence of atypical food selectivity in children with ASD [60,61,62]. We have also reported in this study that ASD cases had significantly lower consumption of various types of fruits and vegetables as well as seafood that are potential dietary sources of Pb exposure in children. Although we accounted for the possible confounding effect of dietary exposures in our multivariable analyses, understanding the biological mechanisms that can explain the lower BPBCs in ASD cases than in TD children requires further investigation.
Although to our knowledge, this study is the first that investigated possible interactive associations of GST genes (GSTP1, GSTM1, and GSTT1) and ASD status in relation to BPbCs, our findings suggest associations of certain GST genotypes with significantly lower BPbCs in children with ASD than in TD controls that are in line with the literature, indicating a possible role of GST genes in detoxification of Pb [10,27,29,63,64,65] and/or their associations with ASD status [14,16]. For example, our findings show significant associations between the presence of at least one Val allele for the GSTP1 Ile105Val polymorphism and lower BPbCs in children with ASD than in TD controls, suggesting a possible role for the Val allele in detoxification of Pb. Although knowledge about the possible biological role of different GSTP1 alleles in detoxification of Pb is very limited, our findings are consistent with another study that investigated the association between cumulative bone Pb biomarkers and cognitive function among a Boston-based prospective cohort of men participating in the Normative Aging Study. Their findings suggested that the GSTP1 Ile105Val polymorphism is an effect modifier for the association between Pb burden and poorer cognitive function. Specifically, they reported that among GSTP1 Val105 variant carriers, higher tibia lead concentration was associated with decreased cognitive function measured by the Mini-Mental State Examination (MMSE) score, which was significantly stronger than the association among men with only GSTP1 Ile alleles (interaction p = 0.01). They also found that the negative association between bone Pb concentration and cognitive function was stronger among participants with more GSTP1 Val105 alleles [29]. Another study, by Yohannes et al., examined the associations between GST gene polymorphisms and blood concentrations of heavy metals including Pb in 140 Pb- and zinc (Zn)-exposed children in Kabwe, Zambia, and reported a univariable significant positive association between the GSTT1 null genotype and BPbCs (β = 0.11, p = 0.02) [65]. Although in our univariable analyses we did not find associations between any of the GST genes and BPbCs, we found that among children with an insertion polymorphism (I/I or I/D genotype) for either GSTT1 or GSTM1, BPbCs were significantly lower in ASD cases than in TD children, which is consistent with the previous report by Yohannes et al. [65] and suggests a possible role of the active versions of these genes in detoxification of Pb. In addition, we identified a significant gene–gene interaction (GSTT1 and GSTP1) in relation to BPbCs that we accounted for in our adjusted analyses, which was in line with the combined effect of GSTT1 and GSTP1 genes in association with BPbC that was reported by Yohannes et al. [65]. Specifically, their findings suggest that while the combination of the GSTT1 null genotype and the GSTP1 Ile/Val genotype was positively associated with blood Pb concentrations (β = 0.19, p < 0.01), having the combination of the GSTT1 null genotype and the GSTP1 Ile/Ile genotype was inversely associated with BPbCs (β = −0.17, p = 0.03). All of these findings suggest that the genotype for GST genes, either individually or in specific combinations (gene–gene interactions), may affect the susceptibility to Pb exposure by regulating Pb detoxification. In addition, these associations also may be dependent on other oxidative stress-related conditions such as ASD status. However, replication of our findings regarding the role of GST polymorphisms in BPbCs of children with and without ASD is warranted in future studies with larger sample sizes and different populations. In addition, understanding the possible biological and behavioral mechanisms that may contribute to variation in the relationships between ASD and BPbCs by certain GST genotypes requires further investigation.

5. Limitations

This study has a number of limitations. First, our assessment of BPbCs did not distinguish the source of Pb exposure (organic vs. inorganic); therefore, distinct sources of Pb exposure were not discussed in detail. In addition, although we previously reported a significant correlation between cord blood and childhood BPbC in Jamaican children (Spearman r = 0.45, p = 0.04) that remained significant after adjusting for the child’s age and sex [66], having a single BPbC assessment at the time of enrollment limited our ability to distinguish whether the concentration was due to chronic or recent Pb exposure. Furthermore, the majority of TD controls in this study were recruited from Kingston, Jamaica, which affected the generalizability of our findings on BPbCs to all Jamaican children. In addition, the activity of GSH or GST enzyme was not measured in our study, although it may further account for the complexity in the relationship between GST genes and Pb concentrations. We also acknowledge that the significant association we found between BPbCs and the GSTP1 rs1695 polymorphism does not directly equate to rs1695 being the true causal polymorphism. In addition, we did not make any adjustments to account for multiple comparisons. Moreover, we had limited ability to establish causal inference from our findings because of the case–control study design. Therefore, the associations reported in this study should be interpreted with caution and warrant replication in similar studies with different populations.

6. Conclusions

In this study, we investigated possible interactions of three GST genes (GSTP1, GSTM1, and GSTT1) and ASD status in relation to BPbCs in Jamaican children age 2–8 years old with and without ASD. Although we did not detect significant interactions between polymorphisms in any of the three GST genes and ASD status in relation to BPbCs, we observed significantly lower BPbCs in ASD cases than in TD controls (age- and sex-matched) only among children with certain GST genotypes, before and after adjusting for SES, parish of child’s birth, consumption of lettuce, fried plantains, and canned fish, as well as the gene–gene interaction between GSTT1 and GSTP1 in relation to BPbC in the adjusted models that involved these two genes. Specifically, using either the dominant or co-dominant genetic model for GSTP1, our findings based on both unadjusted and adjusted models suggest that while among children with the Ile/Ile genotype, there was no significant difference in the GM BPbC of ASD cases and TD controls, among children with at least one GSTP1 Val105 allele (Val/Val or Ile/Val genotypes), ASD cases had significantly lower GM BPbC than TD children. Similarly, our findings show that among children with I* genotypes for either GSTT1 or GSTM1, children with ASD had significantly lower GM BPbC than TD controls, indicating a possible role of the active enzyme encoded by GSTT1 or GSTM1 in detoxification of Pb before and after accounting for the covariates mentioned above. These findings suggest that the presence of at least one Val allele for the GSTP1 Ile105Val polymorphism, as well as active variants of GSTT1 and GSTM1 genes, may be associated with a better Pb detoxification capacity in Jamaican children with ASD than in TD controls. Although these findings are in line with the role for GST genes in detoxification of Pb, oxidative stress, and ASD, since this is the first study to assess the interactive associations of GST genes and ASD status in relation to BPbCs, further investigation in various populations is warranted.

Author Contributions

Conceptualization, M.H.R., M.S.-V., S.K. and J.B.; methodology, M.H.R., M.S.-V., S.K., J.B. and M.L.G.; validation, M.H.R.; formal analysis, M.H.R., S.K. and S.S.; investigation, M.H.R., S.S.-P. and M.S.-V.; resources, M.H.R. and M.S.-V.; data curation, M.S.-V., M.L.G. and S.S.-P.; visualization, M.H. and M.H.R.; writing—original draft preparation, S.K., S.S. and M.H.R.; writing—review and editing, M.H.R., S.K., S.S., J.B., M.H. and K.A.L.; supervision, M.H.R.; project administration, M.H.R and M.S.-V.; funding acquisition, M.H.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research is funded by awards to the University of Texas Health Science Center at Houston (UTHealth) by the following organizations or institutions: 1) National Institute of Environmental Health Sciences (NIEHS): R01ES022165 in 2013; 2) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institutes of Health Fogarty International Center (NIH-FIC): R21HD057808) in 2009; 3) Translational Science Award (NIH CTSA) grant: UL1 RR024148 in 2006; 4) The National Center for Research Resources (NCRR): UL1 TR000371 in 2012; and 5) The National Center for Advancing Translational Sciences (NCATS): UL1 TR003167) in 2019. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD, NIH-FIC, NIEHS, NCRR, or NCATS.

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Committee for the Protection of Human Subjects (CPHS) of the University of Texas Health Science Center at Houston (HSC-SPH-09-0059, Primary Investigator: Mohammad H. Rahbar; 20 March 2009).

Informed Consent Statement

Informed consent was obtained from parents/guardians of all children involved in the study. Children’s assents were also obtained if the child was 7–8 years old.

Data Availability Statement

The data analyzed in this study are from two grants (i.e., R21 and R01). The data from R01 are or will be publicly available through the National Database for Autism Research (NDAR). Data from R21 will also be available upon request from the corresponding author.

Acknowledgments

We acknowledge that study data were collected and managed using the REDCap [67] electronic data capture information system hosted at University of Texas Health Science Center at Houston. We also acknowledge contributions for storing the whole blood samples for the assessments of heavy metal concentrations by colleagues in the Analytical Chemistry Lab at MDHHS, under a service contract.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Flora, G.; Gupta, D.; Tiwari, A. Toxicity of lead: A review with recent updates. Interdiscip. Toxicol. 2012, 5, 47–58. [Google Scholar] [CrossRef] [PubMed]
  2. Canfield, R.L.; Henderson, C.R., Jr.; Cory-Slechta, D.A.; Cox, C.; Jusko, T.A.; Lanphear, B.P. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N. Engl. J Med 2003, 348, 1517–1526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. American Academy of Pediatrics Committee on Environmental Health Lead exposure in children: Prevention, detection, and management. Pediatrics 2005, 116, 1036–1046. [CrossRef] [PubMed] [Green Version]
  4. Mendola, P.; Selevan, S.G.; Gutter, S.; Rice, D. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8, 188–197. [Google Scholar] [CrossRef]
  5. Ettinger, A.S.; Leonard, M.L.; Mason, J. CDC’s Lead Poisoning Prevention Program: A Long-standing Responsibility and Commitment to Protect Children from Lead Exposure. J. Public Health Manag. Pract. 2019, 25, S5–S12. [Google Scholar] [CrossRef] [PubMed]
  6. Ha, M.; Kwon, H.J.; Lim, M.H.; Jee, Y.K.; Hong, Y.C.; Leem, J.H.; Sakong, J.; Bae, J.M.; Hong, S.J.; Roh, Y.M.; et al. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: A report of the children’s health and environment research (CHEER). Neurotoxicology 2009, 30, 31–36. [Google Scholar] [CrossRef] [PubMed]
  7. Bellinger, D.C. Very low lead exposures and children’s neurodevelopment. Curr. Opin. Pediatr 2008, 20, 172–177. [Google Scholar] [CrossRef] [PubMed]
  8. Bellinger, D.C.; Stiles, K.M.; Needleman, H.L. Low-level lead exposure, intelligence and academic achievement: A long-term follow-up study. Pediatrics 1992, 90, 855–861. [Google Scholar] [CrossRef]
  9. Fido, A.; Al-Saad, S. Toxic trace elements in the hair of children with autism. Autism 2005, 9, 290–298. [Google Scholar] [CrossRef] [Green Version]
  10. Alabdali, A.; Al-Ayadhi, L.; El-Ansary, A. A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders. Behav. Brain Funct. 2014, 10, 14. [Google Scholar] [CrossRef] [Green Version]
  11. Lakshmi Priya, M.; Geetha, A. Level of Trace Elements (Copper, Zinc, Magnesium and Selenium) and Toxic Elements (Lead and Mercury) in the Hair and Nail of Children with Autism. Biol. Trace Elem. Res. 2010, 142, 148–158. [Google Scholar] [CrossRef] [PubMed]
  12. Blaurock-Busch, E.; Amin, O.R.; Dessoki, H.H.; Rabah, T. Toxic Metals and Essential Elements in Hair and Severity of Symptoms among Children with Autism. Maedica 2012, 7, 38–48. [Google Scholar] [PubMed]
  13. Yorbik, O.; Kurt, I.; Hasimi, A.; Ozturk, O. Chromium, cadmium, and lead levels in urine of children with autism and typically developing controls. Biol. Trace Elem. Res. 2010, 135, 10–15. [Google Scholar] [CrossRef] [PubMed]
  14. Tian, Y.; Green, P.G.; Stamova, B.; Hertz-Picciotto, I.; Pessah, I.N.; Hansen, R.; Yang, X.; Gregg, J.P.; Ashwood, P.; Jickling, G.; et al. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox. Res. 2011, 19, 1–13. [Google Scholar] [CrossRef] [Green Version]
  15. Rahbar, M.H.; Samms-Vaughan, M.; Lee, M.; Zhang, J.; Hessabi, M.; Bressler, J.; Bach, M.A.; Grove, M.L.; Shakespeare-Pellington, S.; Beecher, C.; et al. Interaction between a Mixture of Heavy Metals (Lead, Mercury, Arsenic, Cadmium, Manganese, Aluminum) and GSTP1, GSTT1, and GSTM1 in Relation to Autism Spectrum Disorder. Res. Autism Spectr. Disord. 2020, 79, 101681. [Google Scholar] [CrossRef] [PubMed]
  16. Abd Wahil, M.S.; Ja’afar, M.H.; Md, I.Z. Assessment of Urinary Lead (Pb) and Essential Trace Elements in Autism Spectrum Disorder: A Case-Control Study Among Preschool Children in Malaysia. Biol. Trace Elem. Res. 2022, 1, 97–121. [Google Scholar] [CrossRef] [PubMed]
  17. Wani, A.L.; Ara, A.; Usmani, J.A. Lead toxicity: A review. Interdiscip. Toxicol. 2015, 8, 55–64. [Google Scholar] [CrossRef] [Green Version]
  18. Perkins, G.A.; Scott, R.; Perez, A.; Ellisman, M.H.; Johnson, J.E.; Fox, D.A. Bcl-xL-mediated remodeling of rod and cone synaptic mitochondria after postnatal lead exposure: Electron microscopy, tomography and oxygen consumption. Mol. Vis. 2012, 18, 3029–3048. [Google Scholar]
  19. Geier, D.A.; King, P.G.; Geier, M.R. Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds. Toxicol. Environ. Chem. 2009, 91, 735–749. [Google Scholar] [CrossRef] [Green Version]
  20. Wu, Q.; Liu, P.; Li, Y.; Du, M.; Xing, X.; Wang, D. Inhibition of ROS elevation and damage to mitochondrial function prevents lead-induced neurotoxic effects on structures and functions of AFD neurons in Caenorhabditis elegans. J. Environ. Sci. 2012, 24, 733–742. [Google Scholar] [CrossRef]
  21. Landrigan, P.J.; Whitworth, R.H.; Baloh, R.W.; Staehling, N.W.; Barthel, W.F.; Rosenblum, B.F. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet 1975, 1, 708–712. [Google Scholar] [CrossRef]
  22. Zhang, Z.J.; Hao, K.; Shi, R.; Zhao, G.; Jiang, G.X.; Song, Y.; Xu, X.; Ma, J. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: A HuGE review and meta-analysis. Am. J. Epidemiol. 2011, 173, 847–857. [Google Scholar] [CrossRef] [PubMed]
  23. Hayes, J.D.; Strange, R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61, 154–166. [Google Scholar] [CrossRef] [PubMed]
  24. Zhou, T.B.; Drummen, G.P.; Jiang, Z.P.; Qin, Y.H. GSTT1 polymorphism and the risk of developing prostate cancer. Am. J. Epidemiol. 2014, 180, 1–10. [Google Scholar] [CrossRef] [Green Version]
  25. Coleman, W.B.; Tsongalis, G.J. Essential Concepts in Molecular Pathology; Academic Press: Cambridge, MA, USA, 2010. [Google Scholar]
  26. Josephy, P.D. Genetic variations in human glutathione transferase enzymes: Significance for pharmacology and toxicology. Hum. Genom. Proteom. 2010, 2010, 876940. [Google Scholar] [CrossRef] [Green Version]
  27. Sirivarasai, J.; Wananukul, W.; Kaojarern, S.; Chanprasertyothin, S.; Thongmung, N.; Ratanachaiwong, W.; Sura, T.; Sritara, P. Association between inflammatory marker, environmental lead exposure, and glutathione S-transferase gene. Biomed. Res. Int. 2013, 2013, 474963. [Google Scholar] [CrossRef]
  28. Kim, J.H.; Lee, K.H.; Yoo, D.H.; Kang, D.; Cho, S.H.; Hong, Y.C. GSTM1 and TNF-alpha gene polymorphisms and relations between blood lead and inflammatory markers in a non-occupational population. Mutat. Res. 2007, 629, 32–39. [Google Scholar] [CrossRef]
  29. Eum, K.D.; Wang, F.T.; Schwartz, J.; Hersh, C.P.; Kelsey, K.; Wright, R.O.; Spiro, A.; Sparrow, D.; Hu, H.; Weisskopf, M.G. Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function. Neurotoxicology 2013, 39, 65–71. [Google Scholar] [CrossRef] [Green Version]
  30. Bjørklund, G.; Meguid, N.A.; El-Bana, M.A.; Tinkov, A.A.; Saad, K.; Dadar, M.; Hemimi, M.; Skalny, A.V.; Hosnedlová, B.; Kizek, R.; et al. Oxidative Stress in Autism Spectrum Disorder. Mol. Neurobiol. 2020, 57, 2314–2332. [Google Scholar] [CrossRef]
  31. Schmidt, R.J.; Hansen, R.L.; Hartiala, J.; Allayee, H.; Schmidt, L.C.; Tancredi, D.J.; Tassone, F.; Hertz-Picciotto, I. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 2011, 22, 476–485. [Google Scholar] [CrossRef] [Green Version]
  32. Ruggeri, B.; Sarkans, U.; Schumann, G.; Persico, A.M. Biomarkers in autism spectrum disorder: The old and the new. Psychopharmacology 2014, 231, 1201–1216. [Google Scholar] [CrossRef] [PubMed]
  33. Rossignol, D.A.; Frye, R.E. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol. 2014, 5, 150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Frustaci, A.; Neri, M.; Cesario, A.; Adams, J.B.; Domenici, E.; Dalla, B.B.; Bonassi, S. Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radic. Biol. Med. 2012, 52, 2128–2141. [Google Scholar] [CrossRef] [PubMed]
  35. Bilbo, S.D.; Nevison, C.D.; Parker, W. A model for the induction of autism in the ecosystem of the human body: The anatomy of a modern pandemic? Microb. Ecol. Health Dis. 2015, 26, 26253. [Google Scholar] [CrossRef]
  36. James, S.J.; Melnyk, S.; Jernigan, S.; Cleves, M.A.; Halsted, C.H.; Wong, D.H.; Cutler, P.; Bock, K.; Boris, M.; Bradstreet, J.J.; et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B, 947–956. [Google Scholar] [CrossRef] [Green Version]
  37. Williams, T.A.; Mars, A.E.; Buyske, S.G.; Stenroos, E.S.; Wang, R.; Factura-Santiago, M.F.; Lambert, G.H.; Johnson, W.G. Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch. Pediatr. Adolesc. Med. 2007, 161, 356–361. [Google Scholar]
  38. Buyske, S.; Williams, T.A.; Mars, A.E.; Stenroos, E.S.; Ming, S.X.; Wang, R.; Sreenath, M.; Factura, M.F.; Reddy, C.; Lambert, G.H.; et al. Analysis of case-parent trios at a locus with a deletion allele: Association of GSTM1 with autism. BMC Genet. 2006, 7, 8. [Google Scholar] [CrossRef] [Green Version]
  39. Rahbar, M.H.; Samms-Vaughan, M.; Ma, J.; Bressler, J.; Loveland, K.A.; Hessabi, M.; Dickerson, A.S.; Grove, M.L.; Shakespeare-Pellington, S.; Beecher, C.; et al. Interaction between GSTT1 and GSTP1 allele variants as a risk modulating-factor for autism spectrum disorders. Res. Autism Spectr. Disord. 2015, 12, 1–9. [Google Scholar] [CrossRef] [Green Version]
  40. Lee, M.; Rahbar, M.H.; Samms-Vaughan, M.; Bressler, J.; Bach, M.A.; Hessabi, M.; Grove, M.L.; Shakespeare-Pellington, S.; Coore, D.C.; Reece, J.A.; et al. A generalized weighted quantile sum approach for analyzing correlated data in the presence of interactions. Biom. J. 2019, 61, 934–954. [Google Scholar] [CrossRef]
  41. Rahbar, M.H.; Samms-Vaughan, M.; Ma, J.; Bressler, J.; Loveland, K.A.; Ardjomand-Hessabi, M.; Dickerson, A.S.; Grove, M.L.; Shakespeare-Pellington, S.; Beecher, C.; et al. Role of Metabolic Genes in Blood Arsenic Concentrations of Jamaican Children with and without Autism Spectrum Disorder. Int. J. Environ. Res. Public Health 2014, 11, 7874–7895. [Google Scholar] [CrossRef] [Green Version]
  42. Rahbar, M.H.; Samms-Vaughan, M.; Saroukhani, S.; Bressler, J.; Hessabi, M.; Grove, M.L.; Shakspeare-Pellington, S.; Loveland, K.A.; Beecher, C.; McLaughlin, W. Associations of Metabolic Genes (GSTT1, GSTP1, GSTM1) and Blood Mercury Concentrations Differ in Jamaican Children with and without Autism Spectrum Disorder. Int. J. Environ. Res. Public Health 2021, 18, 1377. [Google Scholar] [CrossRef] [PubMed]
  43. Rahbar, M.H.; Samms-Vaughan, M.; Pitcher, M.R.; Bressler, J.; Hessabi, M.; Loveland, K.A.; Christian, M.A.; Grove, M.L.; Shakespeare-Pellington, S.; Beecher, C.; et al. Role of Metabolic Genes in Blood Aluminum Concentrations of Jamaican Children with and without Autism Spectrum Disorder. Int. J. Environ. Res. Public Health 2016, 13, 1095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Rahbar, M.H.; Samms-Vaughan, M.; Dickerson, A.S.; Loveland, K.A.; Ardjomand-Hessabi, M.; Bressler, J.; Shakespeare-Pellington, S.; Grove, M.L.; Pearson, D.A.; Boerwinkle, E. Blood manganese concentrations in Jamaican children with and without autism spectrum disorders. Environ. Health 2014, 13, 69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Lord, C.; Rutter, M.; DiLavore, P.C.; Risi, S.; Gotham, K.; Bishop, D.V.; Luyster, R.J.; Guthrie, W. (ADOS-2) Autism Diagnostic Observation Schedule, 2nd ed.; WPS Publish: Torrance, CA, USA, 2012. [Google Scholar]
  46. Rutter, M.; Le, C.A.; Lord, C. Autism Diagnostic Interview-Revised (ADI-R); Western Psychological Services: Los Angeles, CA, USA, 2003. [Google Scholar]
  47. Rutter, M.; Bailey, A.; Lord, C. SCQ: The Social Communication Questionnaire. Manual; Western Psychological Services: Los Angeles, CA, USA, 2003. [Google Scholar]
  48. Rahbar, M.H.; Samms-Vaughan, M.; Dickerson, A.S.; Loveland, K.A.; Ardjomand-Hessabi, M.; Bressler, J.; Lee, M.; Shakespeare-Pellington, S.; Grove, M.L.; Pearson, D.A.; et al. Role of fruits, grains, and seafood consumption in blood cadmium concentrations of Jamaican children with and without Autism Spectrum Disorder. Res. Autism Spectr. Disord. 2014, 8, 1134–1145. [Google Scholar] [CrossRef] [Green Version]
  49. Rahbar, M.H.; Samms-Vaughan, M.; Dickerson, A.S.; Hessabi, M.; Bressler, J.; Desai, C.C.; Shakespeare-Pellington, S.; Reece, J.A.; Morgan, R.; Loveland, K.A.; et al. Concentration of lead, mercury, cadmium, aluminum, arsenic and manganese in umbilical cord blood of Jamaican newborns. Int. J. Environ. Res. Public Health 2015, 12, 4481–4501. [Google Scholar] [CrossRef]
  50. Rahbar, M.H.; Samms-Vaughan, M.; Dickerson, A.S.; Loveland, K.A.; Ardjomand-Hessabi, M.; Bressler, J.; Shakespeare-Pellington, S.; Grove, M.L.; Boerwinkle, E. Factors associated with blood lead concentrations of children in Jamaica. J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. 2015, 50, 529–539. [Google Scholar]
  51. Richardson, A. Logistic Regression: A SelfGÇÉLearning Text, Third Edition by David G. Kleinbaum, Mitchel Klein. Int. Stat. Rev. 2011, 79, 296. [Google Scholar] [CrossRef]
  52. SAS Institute Inc. SAS® 9.4.; SAS Institute Inc.: Cary, NC, USA, 2013. [Google Scholar]
  53. Bach, M.A.; Samms-Vaughan, M.; Hessabi, M.; Bressler, J.; Lee, M.; Zhang, J.; Shakespeare-Pellington, S.; Grove, M.L.; Loveland, K.A.; Rahbar, M.H. Association of polychlorinated biphenyls and organochlorine pesticides with autism spectrum disorder in Jamaican children. Res. Autism Spectr. Disord. 2020, 76, 101587. [Google Scholar] [CrossRef]
  54. Yasuda, H.; Yonashiro, T.; Yoshida, K.; Ishii, T.; Tsutsui, T. Mineral Imbalance in Children with Autistic Disorders. Biomed. Res. Trace Elem. 2005, 16, 285–292. [Google Scholar]
  55. Skalny, A.V.; Simashkova, N.V.; Klyushnik, T.P.; Grabeklis, A.R.; Bjørklund, G.; Skalnaya, M.G.; Nikonorov, A.A.; Tinkov, A.A. Hair toxic and essential trace elements in children with autism spectrum disorder. Metab. Brain Dis. 2017, 32, 195–202. [Google Scholar] [CrossRef]
  56. Rahbar, M.H.; Ibrahim, S.H.; Azam, S.I.; Hessabi, M.; Karim, F.; Kim, S.; Zhang, J.; Gulzar Ali, N.; Loveland, K.A. Concentrations of Lead, Mercury, Arsenic, Cadmium, Manganese, and Aluminum in the Blood of Pakistani Children with and without Autism Spectrum Disorder and Their Associated Factors. Int. J. Environ. Res. Public Health 2021, 18, 8625. [Google Scholar] [CrossRef] [PubMed]
  57. Gangoso, L.; Alvarez-Lloret, P.; Rodriguez-Navarro, A.A.; Mateo, R.; Hiraldo, F.; Donazar, J.A. Long-term effects of lead poisoning on bone mineralization in vultures exposed to ammunition sources. Environ. Pollut. 2009, 157, 569–574. [Google Scholar] [CrossRef] [PubMed]
  58. Sakai, T. Biomarkers of lead exposure. Ind. Health 2000, 38, 127–142. [Google Scholar] [CrossRef] [PubMed]
  59. Barbosa, F., Jr.; Tanus-Santos, J.E.; Gerlach, R.F.; Parsons, P.J. A critical review of biomarkers used for monitoring human exposure to lead: Advantages, limitations, and future needs. Environ. Health Perspect. 2005, 113, 1669–1674. [Google Scholar] [CrossRef] [Green Version]
  60. Bandini, L.G.; Curtin, C.; Phillips, S.; Anderson, S.E.; Maslin, M.; Must, A. Changes in Food Selectivity in Children with Autism Spectrum Disorder. J. Autism Dev. Disord. 2017, 47, 439–446. [Google Scholar] [CrossRef] [Green Version]
  61. Hubbard, K.L.; Anderson, S.E.; Curtin, C.; Must, A.; Bandini, L.G. A comparison of food refusal related to characteristics of food in children with autism spectrum disorder and typically developing children. J. Acad. Nutr. Diet. 2014, 114, 1981–1987. [Google Scholar] [CrossRef] [Green Version]
  62. Sharp, W.G.; Postorino, V.; McCracken, C.E.; Berry, R.C.; Criado, K.K.; Burrell, T.L.; Scahill, L. Dietary Intake, Nutrient Status, and Growth Parameters in Children with Autism Spectrum Disorder and Severe Food Selectivity: An Electronic Medical Record Review. J. Acad. Nutr. Diet. 2018, 118, 1943–1950. [Google Scholar] [CrossRef]
  63. Devóz, P.P.; Reis, M.B.D.; Gomes, W.R.; Maraslis, F.T.; Ribeiro, D.L.; Antunes, L.M.G.; Batista, B.L.; Grotto, D.; Reis, R.M.; Barbosa, F., Jr.; et al. Adaptive epigenetic response of glutathione (GSH)-related genes against lead (Pb)-induced toxicity, in individuals chronically exposed to the metal. Chemosphere 2021, 269, 128758. [Google Scholar] [CrossRef]
  64. Lamichhane, D.K.; Leem, J.H.; Park, C.S.; Ha, M.; Ha, E.H.; Kim, H.C.; Lee, J.Y.; Ko, J.K.; Kim, Y.; Hong, Y.C. Associations between prenatal lead exposure and birth outcomes: Modification by sex and GSTM1/GSTT1 polymorphism. Sci. Total Environ. 2018, 619–620, 176–184. [Google Scholar] [CrossRef]
  65. Yohannes, Y.B.; Nakayama, S.M.M.; Yabe, J.; Toyomaki, H.; Kataba, A.; Nakata, H.; Muzandu, K.; Ikenaka, Y.; Choongo, K.; Ishizuka, M. Glutathione S-transferase gene polymorphisms in association with susceptibility to lead toxicity in lead- and cadmium-exposed children near an abandoned lead-zinc mining area in Kabwe, Zambia. Environ Sci. Pollut. Res. Int. 2022, 29, 66222–66632. [Google Scholar] [CrossRef]
  66. Rahbar, M.H.; Samms-Vaughan, M.; Hessabi, M.; Bressler, J.; Gillani, S.; Grove, M.L.; Shakspeare-Pellington, S.; Loveland, K.A. Correlation between concentrations of four heavy metals in cord blood and childhood blood of Jamaican children. J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. 2021, 56, 1196–1205. [Google Scholar] [CrossRef] [PubMed]
  67. Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table
Table 1. Comparison of ASD and TD control groups with respect to characteristics of children and their parents (344 matched pairs).
Table 1. Comparison of ASD and TD control groups with respect to characteristics of children and their parents (344 matched pairs).
VariablesCategoriesASD Cases (n = 344)
n (%)		TD Controls (n = 344)
n (%)		p Value *
ChildSexMale286 (83.1)286 (83.1)1.00
Age< 48 months97 (28.2)87 (25.3)0.02
≥ 48 months247 (71.8)257 (74.7)
RaceAfro-Caribbean325 (94.5)334 (97.1)0.10
Place of birth
(Parish)		Kingston102 (29.6)216 (62.8)<0.01
Others a242 (70.4)128 (37.2)
Mother’s age b
(at child’s birth)		Age < 35 years276 (80.5)298 (88.2)<0.01
Age ≥ 35 years67 (19.5)40 (11.8)
Father’s age c
(at child’s birth)		Age < 35 years190 (56.2)230 (69.7)<0.01
Age ≥ 35 years148 (43.8)100 (30.3)
Parental education d
(at child’s birth)		Both up to high school †128 (37.7)169 (51.7)<0.01
At least one beyond high school ††210 (62.3)158 (48.3)
Socioeconomic status (SES)Car ownership186 (54.1)144 (41.9)<0.01
GSTP1eIle/Ile86 (25.2)91 (26.5)0.48
Ile/Val190 (55.7)175 (51.0)
Val/Val65 (19.1)77 (22.4)
GSTM1fDD g103 (30.3)82 (24.0)0.07
I/I or I/D h237 (69.7)259 (76.0)
GSTT1iDD g84 (24.6)88 (25.9)0.60
I/I or I/D h257 (75.4)252 (74.1)
* p values are based on Wald’s test in conditional logistic regression models. † Up to high school education refers to those who attended primary/jr. secondary, and secondary/high/technical schools. †† Beyond high school education indicates those who attended a vocational or tertiary college or university. a Other parishes include all 12 parishes in Jamaica, except for Kingston parish as described previously [53]. b Mother’s age was missing for 1 ASD case and 6 TD control children. c Father’s age was missing for 6 ASD case and 14 TD control children. d Parental education was missing for 7 ASD case and 17 TD control children. e GSTP1 genotype was missing for 3 ASD case and 1 TD control children. f GSTM1 genotype was missing for 4 ASD case and 3 TD control children. g DD indicates the null alleles for GSTT1 and GSTM1. h I/I or I/D indicate the homozygote (I/I) or a heterozygote (I/D) for GSTT1 and GSTM1. i GSTT1 was missing for 3 ASD case and 4 TD control children.
Table
Table 2. Findings from conditional logistic regression (CLR) models related to associations between dietary or environmental factors and ASD case status (344 matched pairs).
Table 2. Findings from conditional logistic regression (CLR) models related to associations between dietary or environmental factors and ASD case status (344 matched pairs).
Exposure VariablesCategoryASD Cases
n (%)		TD Controls
n (%)		MOR95% CIp Value b
Fruit and vegetable consumption aRoot vegetablesYam, sweet potato, or dasheen199 (58.0)238 (69.2)0.59(0.43, 0.82)<0.01
Carrot or pumpkin255 (74.3)299 (86.9)0.44(0.30, 0.67)<0.01
Leafy vegetablesLettuce145 (42.3)213 (61.9)0.39(0.28, 0.56)<0.01
Callaloo, broccoli, or
pak choi		240 (70.0)280 (81.4)0.51(0.35, 0.75)<0.01
Cabbage161 (46.9)215 (62.5)0.51(0.37, 0.70)<0.01
FruitsTomatoes190 (55.4)255 (74.1)0.43(0.31, 0.61)<0.01
Ackee151 (44.0)237 (68.9)0.30(0.20, 0.43)<0.01
Avocado128 (37.3)208 (60.5)0.35(0.25, 0.50)<0.01
Green banana199 (58.0)243 (70.6)0.55(0.40, 0.77)<0.01
Fried plantains247 (72.0)292 (84.9)0.48(0.33, 0.69)<0.01
Seafood consumptionSalt water fish213 (61.9)236 (68.6)0.71(0.50, 1.00)0.05
Fresh water fish (pond fish, tilapia)102 (29.7)106 (30.8)0.94(0.66, 1.34)0.72
Sardine, mackerel (canned fish)253 (73.6)289 (84.0)0.52(0.35, 0.77)<0.01
Tuna (canned fish)103 (29.9)121 (35.2)0.78(0.56, 1.08)0.13
Salted fish (pickled mackerel)220 (64.0)271 (78.8)0.50(0.36, 0.70)<0.01
Shellfish (lobsters, crabs)17 (4.9)47 (13.7)0.33(0.19, 0.60)<0.01
Shrimp34 (9.9)60 (17.4)0.54(0.34, 0.84)0.01
a For all variables under fruit and vegetable consumption, data were missing for one ASD case; b p values are based on Wald’s test in the conditional logistic regression models.
Table
Table 3. Findings from univariable general linear models that assess associations of various independent variables with blood Pb concentrations (344 matched pairs) of Jamaican children (total n = 688).
Table 3. Findings from univariable general linear models that assess associations of various independent variables with blood Pb concentrations (344 matched pairs) of Jamaican children (total n = 688).
VariablesCategoryYesNop Value **
Mean Pb * (μg/dL)NMean Pb * (μg/dL)N
ChildASD statusASD1.743442.27344<0.01
AgeAge > 48 (months)2.295041.351840.02
SexMale1.995721.991160.97
Place of birth (Parish)Kingston2.393181.70370<0.01
Socioeconomic status (SES)Own a car1.723302.28358<0.01
Mother’s age (at child’s birth) a≥35 years1.731072.045740.08
Parental education levels
(at child’s birth) b		At least one of the two parents had education beyond high school1.753682.26296<0.01
Fruit and vegetable consumption cRoot vegetablesYam, sweet potato, or dasheen2.114371.792500.03
Carrot or pumpkin2.075541.661330.01
Leafy vegetablesLettuce2.023581.953290.65
Callaloo, broccoli, or pak choi2.065201.771670.07
Cabbage2.063761.903110.29
FruitsTomatoes2.164451.71242<0.01
Ackee2.263881.68299<0.01
Avocado2.203361.80351<0.01
Green banana2.104421.802450.05
Fried plantains2.095391.65148<0.01
Seafood consumptionSalt water fish2.104491.802390.05
Fresh water fish (pond fish, tilapia)2.282081.884800.02
Sardine, mackerel (canned fish)2.135421.55146<0.01
Tuna (canned fish)2.012241.984640.83
Salted fish (pickled mackerel)2.144911.66197<0.01
Shellfish (lobsters, crabs)2.69641.936240.01
Shrimp2.18941.965940.29
Genes
GSTT1 (n = 337 pairs)
GSTM1 (n = 337 pairs)
GSTP1 (n = 340 pairs)		GSTT1 (I *) d1.965092.071720.52
GSTM1 (I *) d2.034961.901850.40
GSTP1 (Ile/Ile)1.961772.005110.77
GSTP1 (Val/Val)2.003651.983230.87
GSTP1 (Ile/Val)2.021421.985460.85
* Mean Pb indicates the geometric mean of Pb = Exp. [Mean (ln Pb)]; ** p values are based on GLMs that compare geometric mean blood Pb concentrations between children in the two groups; a Mother’s age was missing for 7 participants; b Parental education level was missing for 24 participants; c Fruit and vegetable consumption was missing for one participant; d I* indicates the homozygote (I/I) or a heterozygote (I/D) for GSTT1 and GSTM1.
Table
Table 4. Unadjusted and adjusted geometric mean blood Pb concentration (GM BPbC) by GST genotypes based on general linear models (GLMs) that include interaction between GST genes and ASD case status (ASD and TD control) *.
Table 4. Unadjusted and adjusted geometric mean blood Pb concentration (GM BPbC) by GST genotypes based on general linear models (GLMs) that include interaction between GST genes and ASD case status (ASD and TD control) *.
ModelsGene(Column A) Genotypes ComparedReferent GenotypesGroupUnadjusted GM BPbC
(μg/dL) a		Adjusted GM BPbC
(μg/dL) b
GM BPbC with Genotypes in Column A cGM BPbC with Referent Genotypes cp Value dGM BPbC with Genotypes in Column A cGM BPbC with Referent Genotypes cp Value d
Co-dominant e †GSTP1Ile/IleIle/ValTD Control2.142.310.511.782.130.16
GSTP1Ile/IleIle/ValASD Case1.741.780.871.551.780.25
GSTP1Ile/IleVal/ValTD Control2.142.300.611.781.940.56
GSTP1Ile/IleVal/ValASD Case1.741.680.801.551.500.82
GSTP1Ile/ValVal/ValTD Control2.312.300.962.131.940.45
GSTP1Ile/ValVal/ValASD Case1.781.680.671.781.500.19
Dominant f ††GSTP1DOMIle/Val or Val/ValIle/IleTD Control2.312.140.502.051.790.26
GSTP1DOMIle/Val or Val/ValIle/IleASD Case1.751.740.961.711.550.39
Recessive g †††GSTP1RECVal/ValIle/Ile or Ile/ValTD Control2.302.250.861.922.020.67
GSTP1RECVal/ValIle/Ile or Ile/ValASD Case1.681.760.711.491.720.26
Recessive ⸸GSTT1I/I or I/DDDTD Control2.262.290.891.911.990.71
I/I or I/DDDASD Case1.721.840.541.611.600.97
Recessive ‡GSTM1I/I or I/DDDTD Control2.262.310.842.041.810.34
I/I or I/DDDASD Case1.781.670.541.711.580.48
* Results are based on number of pairs reported in Table 3 for GSTP1, GSTM1, and GSTT1. GM BPbC: geometric mean blood Pb concentration. a In the unadjusted GLMs, the independent variables include pairs, ASD status, GST gene, and GST gene interaction with ASD status; b In multivariable GLMs in addition to the variables in the unadjusted model, we adjusted for place of child’s birth (parish), SES (car ownership by the family), and consumption of lettuce, fried plantains, and sardine or mackerel fish. Additionally, we accounted for the interaction between GST genes (GSTT1*GSTP1 interaction) in relation to BPbCs in adjusted models related to GSTP1 and GSTT1 genes; c Mean Pb indicates the geometric mean of Pb = Exp. [Mean (ln Pb)]; d p values are for the comparison of mean blood Pb concentrations of children with genotypes in “Column A” compared to those with “referent genotypes”, stratified by ASD case status (ASD and TD control), based on CONTRAST statement in the SAS program for GLMs as described in the Methods section; e GSTP1 in the co-dominant model has three categories (Ile/Ile, Ile/Val, and Val/Val); f GSTP1 (DOM) = GSTP1 in the dominant model has two categories (Val/Val or Ile/Val, Ile/Ile); g GSTP1 (REC) = GSTP1 in the recessive model has two categories (Val/Val, Ile/Ile or Ile/Val). † Overall interaction p value = 0.86 and 0.81 for unadjusted and adjusted models, respectively. †† Overall interaction p value = 0.66 and 0.83 for unadjusted and adjusted models, respectively. ††† Overall interaction p value = 0.68 and 0.54 for unadjusted and adjusted models, respectively. ⸸ Overall interaction p value = 0.73 and 0.77 for unadjusted and adjusted models, respectively. ‡ Overall interaction p value = 0.57 and 0.82 for unadjusted and adjusted models, respectively.
Table
Table 5. Unadjusted and adjusted geometric mean blood Pb concentration (GM BPbC) by ASD status (ASD and TD control) based on general linear models (GLMs) that include interaction between GST genotypes and ASD case status (ASD and TD control) *.
Table 5. Unadjusted and adjusted geometric mean blood Pb concentration (GM BPbC) by ASD status (ASD and TD control) based on general linear models (GLMs) that include interaction between GST genotypes and ASD case status (ASD and TD control) *.
GeneModels(Column A)
Group Compared		Referent GroupGenotypesUnadjusted Model (μg/dL) aAdjusted Model (μg/dL) b
GM BPbC with Group Compared in Column A cGM BPbC with Referent Group cp Value dGM BPbC Group Compared in Column A cGM BPbC with Referent Group cp Value d
GSTP1Co-dominant e †ASD CaseTD ControlIle/Ile1.742.140.111.551.780.28
ASD CaseTD ControlIle/Val1.782.31<0.011.782.130.03
ASD CaseTD ControlVal/Val1.682.300.021.501.940.06
Dominant f ††ASD CaseTD ControlIle/Ile1.742.140.101.551.790.25
ASD CaseTD ControlVal/Val or Ile/Val1.752.31<0.011.712.050.01
Recessive g †††ASD CaseTD ControlIle/Ile or Ile/Val1.762.25<0.011.722.020.06
ASD CaseTD ControlVal/Val1.682.300.021.491.920.01
GSTT1Recessive ⸸ASD CaseTD ControlDD1.842.290.091.601.990.09
ASD CaseTD ControlI/I or I/D1.722.26<0.011.611.910.01
GSTM1Recessive ‡ASD CaseTD ControlDD1.672.310.011.581.810.28
ASD CaseTD ControlI/I or I/D1.782.26<0.011.712.040.01
* Results are based on number of pairs reported in Table 3 for GSTP1, GSTM1, and GSTT1. GM BPbC: geometric mean blood Pb concentration of children. a In the unadjusted GLMs, the independent variables include pairs, ASD status, GST gene, and GST gene interaction with ASD; b In multivariable GLMs, in addition to the variables in the unadjusted model, we adjusted for place of child’s birth (parish), SES (car ownership by the family), and consumption of lettuce, fried plantains, and sardine or mackerel fish. Additionally, we accounted for the interaction between GST genes (GSTT1*GSTP1 interaction) in relation to blood Pb concentrations in adjusted models related to GSTP1 and GSTT1 genes; c Mean Pb indicates the geometric mean of Pb = Exp. [Mean (ln Pb)]; d p values are for the comparison of mean blood Pb concentrations of children with ASD case status in “Column A” compared to those with TD control status in “referent group”, stratified by GST genotypes, based on CONTRAST statement in the SAS program for GLMs as described in the Methods section; e GSTP1 in the co-dominant model has three categories (Ile/Ile, Ile/Val, and Val/Val); f GSTP1 (DOM) = GSTP1 in the dominant model has two categories (Val/Val or Ile/Val, Ile/Ile); g GSTP1 (REC) = GSTP1 in the recessive model has two categories (Val/Val, Ile/Ile or Ile/Val). † Overall interaction p value = 0.86 and 0.81 for unadjusted and adjusted models, respectively. †† Overall interaction p value = 0.66 and 0.83 for unadjusted and adjusted models, respectively. ††† Overall interaction p value = 0.68 and 0.54 for unadjusted and adjusted models, respectively. ⸸ Overall interaction p value = 0.73 and 0.77 for unadjusted and adjusted models, respectively. ‡ Overall interaction p value = 0.57 and 0.82 for unadjusted and adjusted models, respectively.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rahbar, M.H.; Samms-Vaughan, M.; Kim, S.; Saroukhani, S.; Bressler, J.; Hessabi, M.; Grove, M.L.; Shakspeare-Pellington, S.; Loveland, K.A. Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder. Genes 2022, 13, 975. https://doi.org/10.3390/genes13060975

AMA Style

Rahbar MH, Samms-Vaughan M, Kim S, Saroukhani S, Bressler J, Hessabi M, Grove ML, Shakspeare-Pellington S, Loveland KA. Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder. Genes. 2022; 13(6):975. https://doi.org/10.3390/genes13060975

Chicago/Turabian Style

Rahbar, Mohammad H., Maureen Samms-Vaughan, Sori Kim, Sepideh Saroukhani, Jan Bressler, Manouchehr Hessabi, Megan L. Grove, Sydonnie Shakspeare-Pellington, and Katherine A. Loveland. 2022. "Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder" Genes 13, no. 6: 975. https://doi.org/10.3390/genes13060975

APA Style

Rahbar, M. H., Samms-Vaughan, M., Kim, S., Saroukhani, S., Bressler, J., Hessabi, M., Grove, M. L., Shakspeare-Pellington, S., & Loveland, K. A. (2022). Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder. Genes, 13(6), 975. https://doi.org/10.3390/genes13060975

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop